speb/financial-data huggingface dataset:
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Payable: -552000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -552000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -1205000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 2000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -1205000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 1057000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock: 50679000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -847000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 77456000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 84802000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 22258000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Assets: 74817000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 1904000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Debt: 2580000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 4484000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 86406000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -91000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -91000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 1115000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 1115000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 7024725551.00
CVS.TO income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.42
CVS.TO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 2943000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — EBIT: 4712000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — EBITDA: 5827000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — End Cash Position: 9769000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: -2318000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 3400000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Gain Loss On Sale Of Business: 0.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 201000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Goodwill: 85478000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 110548000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Gross PPE: 27778000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Gross Profit: 15624000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 1339000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Interest Expense: 774000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 774000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Inventory: 17770000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 140567000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -874000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 27626000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 32407000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 13330000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 60531000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 73861000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -1518000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Minority Interest: 181000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Minority Interests: -14000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -5000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Net Debt: 53569000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income: 2943000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 2943000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2957000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2943000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2943000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2957000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2957000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Interest Income: -774000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -27000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: -1518000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -1518000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -774000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -56000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 7000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Net PPE: 27778000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -849000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 0.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -33092000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 3771000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 3771000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 5827000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Normalized Income: 2943000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 4249000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Operating Income: 4680000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Operating Revenue: 100426000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 1273000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 4253000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Current Borrowings: 2580000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1075000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 201000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Other Income Expense: 32000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 25070000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Investments: 4781000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7424000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 11299000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 32000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 10944000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Payable: 41667000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Properties: 27778000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Receivables: 20848000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 2260000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Payables: 58589000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 80847000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CVS.TO income_statement (quarterly, 2026-03-31) — Pretax Income: 3938000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 103000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -5000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -4186000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -849000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Receivables: 40992000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 84802000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 1115000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -1518000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 63282000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 4159000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Share Issued: 1788000000.00
CVS.TO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 266000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 77456000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -33092000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CVS.TO income_statement (quarterly, 2026-03-31) — Tax Provision: 981000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.25
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Assets: 252974000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 137987000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Debt: 78345000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 77637000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Total Expenses: 95746000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 175337000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 178157000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 88931000000.00
CVS.TO income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 4680000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 515000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 36706000000.00
CVS.TO balance_sheet (quarterly, 2026-03-31) — Working Capital: -11589000000.00
CVSA cash_flow (annual, 2021-06-30) — Asset Impairment Charge: 1211000.00
CVSA balance_sheet (annual, 2021-06-30) — Assets Held For Sale Current: 48315000.00
CVSA cash_flow (annual, 2021-06-30) — Cash From Discontinued Financing Activities: 0.00
CVSA cash_flow (annual, 2021-06-30) — Changes In Account Receivables: 15443000.00
CVSA balance_sheet (annual, 2021-06-30) — Current Debt: 3000000.00
CVSA cash_flow (annual, 2021-06-30) — Effect Of Exchange Rate Changes: 534000.00
CVSA balance_sheet (annual, 2021-06-30) — Liabilities Heldfor Sale Non Current: 33517000.00
CVSA balance_sheet (annual, 2021-06-30) — Minority Interest: 1790000.00
CVSA income_statement (annual, 2021-06-30) — Minority Interests: 434000.00
CVSA cash_flow (annual, 2021-06-30) — Net Business Purchase And Sale: 0.00
CVSA cash_flow (annual, 2021-06-30) — Other Cash Adjustment Outside Changein Cash: -18236000.00
CVSA balance_sheet (annual, 2021-06-30) — Other Current Borrowings: 3000000.00
CVSA balance_sheet (annual, 2021-06-30) — Other Current Liabilities: 59913000.00
CVSA income_statement (annual, 2021-06-30) — Other Non Operating Income Expenses: 6732000.00
CVSA balance_sheet (annual, 2021-06-30) — Preferred Securities Outside Stock Equity: 1790000.00
CVSA balance_sheet (annual, 2021-06-30) — Prepaid Assets: 128217000.00
CVSA cash_flow (annual, 2021-06-30) — Purchase Of Business: 0.00
CVSA income_statement (annual, 2022-06-30) — +Operating Expense: 566494000.00
CVSA income_statement (annual, 2022-06-30) — +Total Revenue: 1381842000.00
CVSA balance_sheet (annual, 2022-06-30) — Accounts Payable: 57140000.00
CVSA balance_sheet (annual, 2022-06-30) — Accounts Receivable: 81635000.00
CVSA balance_sheet (annual, 2022-06-30) — Accumulated Depreciation: -376328000.00
CVSA balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 521848000.00
CVSA balance_sheet (annual, 2022-06-30) — Allowance For Doubtful Accounts Receivable: -34363000.00
CVSA cash_flow (annual, 2022-06-30) — Amortization Cash Flow: 97274000.00
CVSA cash_flow (annual, 2022-06-30) — Amortization Of Intangibles: 97274000.00
CVSA balance_sheet (annual, 2022-06-30) — Assets Held For Sale Current: 0.00
CVSA income_statement (annual, 2022-06-30) — Basic Average Shares: 48388000.00
CVSA income_statement (annual, 2022-06-30) — Basic EPS: 6.57
CVSA cash_flow (annual, 2022-06-30) — Beginning Cash Position: 1313616000.00
CVSA balance_sheet (annual, 2022-06-30) — Buildings And Improvements: 342236000.00
CVSA cash_flow (annual, 2022-06-30) — Capital Expenditure: -31054000.00
CVSA cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -31054000.00
CVSA balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 227826000.00
CVSA balance_sheet (annual, 2022-06-30) — Capital Stock: 818000.00
CVSA balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 346973000.00
CVSA balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 346973000.00
CVSA cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: -424476000.00
CVSA cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -1509285000.00
CVSA cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Operating Activities: 164002000.00
CVSA cash_flow (annual, 2022-06-30) — Cash From Discontinued Financing Activities: 0.00
CVSA cash_flow (annual, 2022-06-30) — Cash From Discontinued Investing Activities: 957481000.00
CVSA cash_flow (annual, 2022-06-30) — Cash From Discontinued Operating Activities: -153401000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Account Payable: -15724000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Accrued Expense: -28423000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Other Current Liabilities: -49147000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Other Working Capital: 54311000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Payable: -15724000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Payables And Accrued Expense: -44147000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Prepaid Assets: -2827000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Receivables: -41391000.00
CVSA cash_flow (annual, 2022-06-30) — Change In Working Capital: -83201000.00
CVSA cash_flow (annual, 2022-06-30) — Changes In Account Receivables: -41391000.00
CVSA cash_flow (annual, 2022-06-30) — Changes In Cash: -965679000.00
CVSA balance_sheet (annual, 2022-06-30) — Common Stock: 818000.00
CVSA balance_sheet (annual, 2022-06-30) — Common Stock Equity: 1491386000.00
CVSA cash_flow (annual, 2022-06-30) — Common Stock Payments: -120000000.00
CVSA balance_sheet (annual, 2022-06-30) — Construction In Progress: 11188000.00
CVSA income_statement (annual, 2022-06-30) — Cost Of Revenue: 659776000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Accrued Expenses: 165916000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Assets: 557104000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 50781000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 50781000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Deferred Liabilities: 149810000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Deferred Revenue: 149810000.00
CVSA balance_sheet (annual, 2022-06-30) — Current Liabilities: 423647000.00
CVSA cash_flow (annual, 2022-06-30) — Deferred Income Tax: -544000.00
CVSA cash_flow (annual, 2022-06-30) — Deferred Tax: -544000.00
CVSA cash_flow (annual, 2022-06-30) — Depreciation: 89322000.00
CVSA cash_flow (annual, 2022-06-30) — Depreciation Amortization Depletion: 186596000.00
CVSA cash_flow (annual, 2022-06-30) — Depreciation And Amortization: 186596000.00
CVSA income_statement (annual, 2022-06-30) — Diluted Average Shares: 48388000.00
CVSA income_statement (annual, 2022-06-30) — Diluted EPS: 6.57
CVSA income_statement (annual, 2022-06-30) — Diluted NI Availto Com Stockholders: 310991000.00
CVSA income_statement (annual, 2022-06-30) — EBIT: 47446000.00
CVSA income_statement (annual, 2022-06-30) — EBITDA: 234042000.00
CVSA cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 0.00
CVSA cash_flow (annual, 2022-06-30) — End Cash Position: 347937000.00
CVSA cash_flow (annual, 2022-06-30) — Financing Cash Flow: -424476000.00
CVSA cash_flow (annual, 2022-06-30) — Free Cash Flow: -20453000.00
CVSA cash_flow (annual, 2022-06-30) — Gain Loss On Investment Securities: 3271000.00
CVSA cash_flow (annual, 2022-06-30) — Gain Loss On Sale Of PPE: 3501000.00
CVSA income_statement (annual, 2022-06-30) — Gain On Sale Of Ppe: 0.00
CVSA income_statement (annual, 2022-06-30) — Gain On Sale Of Security: -4525000.00
CVSA balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (annual, 2022-06-30) — Goodwill: 961262000.00
CVSA balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 1834839000.00
CVSA balance_sheet (annual, 2022-06-30) — Gross Accounts Receivable: 115998000.00
CVSA balance_sheet (annual, 2022-06-30) — Gross PPE: 844249000.00
CVSA income_statement (annual, 2022-06-30) — Gross Profit: 722066000.00
CVSA cash_flow (annual, 2022-06-30) — Income Tax Paid Supplemental Data: 94355000.00
CVSA income_statement (annual, 2022-06-30) — Interest Expense: 98940000.00
CVSA income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 98940000.00
CVSA income_statement (annual, 2022-06-30) — Interest Income: 3820000.00
CVSA income_statement (annual, 2022-06-30) — Interest Income Non Operating: 3820000.00
CVSA cash_flow (annual, 2022-06-30) — Interest Paid Supplemental Data: 107093000.00
CVSA balance_sheet (annual, 2022-06-30) — Invested Capital: 2330294000.00
CVSA cash_flow (annual, 2022-06-30) — Investing Cash Flow: -551804000.00
CVSA cash_flow (annual, 2022-06-30) — Issuance Of Debt: 850000000.00
CVSA balance_sheet (annual, 2022-06-30) — Land And Improvements: 44478000.00
CVSA balance_sheet (annual, 2022-06-30) — Liabilities Heldfor Sale Non Current: 0.00
CVSA balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 177045000.00
CVSA balance_sheet (annual, 2022-06-30) — Long Term Debt: 838908000.00
CVSA balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 1015953000.00
CVSA cash_flow (annual, 2022-06-30) — Long Term Debt Issuance: 850000000.00
CVSA cash_flow (annual, 2022-06-30) — Long Term Debt Payments: -1079713000.00
CVSA balance_sheet (annual, 2022-06-30) — Minority Interest: 0.00
CVSA income_statement (annual, 2022-06-30) — Minority Interests: 0.00
CVSA cash_flow (annual, 2022-06-30) — Net Business Purchase And Sale: -1488054000.00
CVSA cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: -120000000.00
CVSA balance_sheet (annual, 2022-06-30) — Net Debt: 491935000.00
CVSA income_statement (annual, 2022-06-30) — Net Income: 310991000.00
CVSA income_statement (annual, 2022-06-30) — Net Income Common Stockholders: 310991000.00
CVSA income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -35955000.00
CVSA income_statement (annual, 2022-06-30) — Net Income Discontinuous Operations: 346946000.00
CVSA income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: 310991000.00
CVSA income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -35955000.00
CVSA cash_flow (annual, 2022-06-30) — Net Income From Continuing Operations: -35955000.00
CVSA income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: 310991000.00
CVSA income_statement (annual, 2022-06-30) — Net Interest Income: -120124000.00
CVSA cash_flow (annual, 2022-06-30) — Net Investment Purchase And Sale: -177000.00
CVSA cash_flow (annual, 2022-06-30) — Net Issuance Payments Of Debt: -229713000.00
CVSA cash_flow (annual, 2022-06-30) — Net Long Term Debt Issuance: -229713000.00
CVSA income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -120124000.00
CVSA cash_flow (annual, 2022-06-30) — Net Other Financing Charges: -84177000.00
CVSA cash_flow (annual, 2022-06-30) — Net Other Investing Changes: 10000000.00
CVSA balance_sheet (annual, 2022-06-30) — Net PPE: 467921000.00
CVSA balance_sheet (annual, 2022-06-30) — Net Tangible Assets: -343453000.00
CVSA balance_sheet (annual, 2022-06-30) — Non Current Deferred Assets: 51093000.00
CVSA balance_sheet (annual, 2022-06-30) — Non Current Deferred Liabilities: 25554000.00
CVSA balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Assets: 51093000.00
CVSA balance_sheet (annual, 2022-06-30) — Non Current Deferred Taxes Liabilities: 25554000.00
CVSA income_statement (annual, 2022-06-30) — Normalized EBITDA: 322092000.00
CVSA income_statement (annual, 2022-06-30) — Normalized Income: 25503900.00
CVSA cash_flow (annual, 2022-06-30) — Operating Cash Flow: 10601000.00
CVSA cash_flow (annual, 2022-06-30) — Operating Gains Losses: 4700000.00
CVSA income_statement (annual, 2022-06-30) — Operating Income: 155572000.00
CVSA income_statement (annual, 2022-06-30) — Operating Revenue: 1381842000.00
CVSA balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 45177000.00
CVSA cash_flow (annual, 2022-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
CVSA balance_sheet (annual, 2022-06-30) — Other Current Assets: 127532000.00
CVSA balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: -2227000.00
CVSA income_statement (annual, 2022-06-30) — Other Income Expense: -86942000.00
CVSA balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 873577000.00
CVSA cash_flow (annual, 2022-06-30) — Other Non Cash Items: 42654000.00
CVSA balance_sheet (annual, 2022-06-30) — Other Non Current Assets: 119283000.00
CVSA balance_sheet (annual, 2022-06-30) — Other Non Current Liabilities: 73700000.00
CVSA income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 1108000.00
CVSA balance_sheet (annual, 2022-06-30) — Other Properties: 446347000.00
CVSA income_statement (annual, 2022-06-30) — Other Special Charges: 4699000.00
CVSA balance_sheet (annual, 2022-06-30) — Payables: 57140000.00
CVSA balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 223056000.00
CVSA balance_sheet (annual, 2022-06-30) — Prepaid Assets: 126467000.00
CVSA income_statement (annual, 2022-06-30) — Pretax Income: -51494000.00
CVSA cash_flow (annual, 2022-06-30) — Proceeds From Stock Option Exercised: 9414000.00
CVSA balance_sheet (annual, 2022-06-30) — Properties: 0.00
CVSA cash_flow (annual, 2022-06-30) — Provisionand Write Offof Assets: 27141000.00
CVSA cash_flow (annual, 2022-06-30) — Purchase Of Business: -1488054000.00
CVSA cash_flow (annual, 2022-06-30) — Purchase Of Investment: -3624000.00
CVSA balance_sheet (annual, 2022-06-30) — Receivables: 81635000.00
CVSA income_statement (annual, 2022-06-30) — Reconciled Cost Of Revenue: 659776000.00
CVSA income_statement (annual, 2022-06-30) — Reconciled Depreciation: 186596000.00
CVSA cash_flow (annual, 2022-06-30) — Repayment Of Debt: -1079713000.00
CVSA cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -120000000.00
CVSA balance_sheet (annual, 2022-06-30) — Restricted Cash: 964000.00
CVSA income_statement (annual, 2022-06-30) — Restructuring And Mergern Acquisition: 78826000.00
CVSA balance_sheet (annual, 2022-06-30) — Retained Earnings: 2310396000.00
CVSA cash_flow (annual, 2022-06-30) — Sale Of Investment: 3447000.00
CVSA income_statement (annual, 2022-06-30) — Selling General And Administration: 566494000.00
CVSA balance_sheet (annual, 2022-06-30) — Share Issued: 81796000.00
CVSA income_statement (annual, 2022-06-30) — Special Income Charges: -83525000.00
CVSA cash_flow (annual, 2022-06-30) — Stock Based Compensation: 22611000.00
CVSA balance_sheet (annual, 2022-06-30) — Stockholders Equity: 1491386000.00
CVSA balance_sheet (annual, 2022-06-30) — Tangible Book Value: -343453000.00
CVSA income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: -26591100.00
CVSA income_statement (annual, 2022-06-30) — Tax Provision: -15539000.00
CVSA income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.30
CVSA balance_sheet (annual, 2022-06-30) — Total Assets: 3030240000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Capitalization: 2330294000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Debt: 1066734000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 1491386000.00
CVSA income_statement (annual, 2022-06-30) — Total Expenses: 1226270000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 1538854000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 2473136000.00
CVSA balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 1115207000.00
CVSA income_statement (annual, 2022-06-30) — Total Operating Income As Reported: 76746000.00
CVSA income_statement (annual, 2022-06-30) — Total Other Finance Cost: 21184000.00
CVSA income_statement (annual, 2022-06-30) — Total Unusual Items: -88050000.00
CVSA income_statement (annual, 2022-06-30) — Total Unusual Items Excluding Goodwill: -88050000.00
CVSA balance_sheet (annual, 2022-06-30) — Treasury Shares Number: 36619000.00
CVSA balance_sheet (annual, 2022-06-30) — Treasury Stock: 1339449000.00
CVSA balance_sheet (annual, 2022-06-30) — Working Capital: 133457000.00
CVSA income_statement (annual, 2023-06-30) — +Operating Expense: 586009000.00
CVSA income_statement (annual, 2023-06-30) — +Total Revenue: 1450826000.00
CVSA balance_sheet (annual, 2023-06-30) — Accounts Payable: 81812000.00
CVSA balance_sheet (annual, 2023-06-30) — Accounts Receivable: 102749000.00
CVSA balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: -338629000.00
CVSA balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 568761000.00
CVSA balance_sheet (annual, 2023-06-30) — Allowance For Doubtful Accounts Receivable: -31326000.00
CVSA cash_flow (annual, 2023-06-30) — Amortization Cash Flow: 61239000.00
CVSA cash_flow (annual, 2023-06-30) — Amortization Of Intangibles: 61239000.00
CVSA income_statement (annual, 2023-06-30) — Basic Average Shares: 44781000.00
CVSA income_statement (annual, 2023-06-30) — Basic EPS: 2.08
CVSA cash_flow (annual, 2023-06-30) — Beginning Cash Position: 347937000.00
CVSA balance_sheet (annual, 2023-06-30) — Buildings And Improvements: 206349000.00
CVSA cash_flow (annual, 2023-06-30) — Capital Expenditure: -26014000.00
CVSA cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -26014000.00
CVSA balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 201114000.00
CVSA balance_sheet (annual, 2023-06-30) — Capital Stock: 822000.00
CVSA balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 272194000.00
CVSA balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 272194000.00
CVSA cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: -288515000.00
CVSA cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: 26913000.00
CVSA cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Operating Activities: 194690000.00
CVSA cash_flow (annual, 2023-06-30) — Cash From Discontinued Investing Activities: -3174000.00
CVSA cash_flow (annual, 2023-06-30) — Cash From Discontinued Operating Activities: -2776000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Account Payable: 24744000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Accrued Expense: -15442000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Other Current Assets: -13873000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Other Current Liabilities: -59188000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Other Working Capital: 6957000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Payable: 24744000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Payables And Accrued Expense: 9302000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Prepaid Assets: 9324000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Receivables: -56309000.00
CVSA cash_flow (annual, 2023-06-30) — Change In Working Capital: -103787000.00
CVSA cash_flow (annual, 2023-06-30) — Changes In Account Receivables: -37614000.00
CVSA cash_flow (annual, 2023-06-30) — Changes In Cash: -72862000.00
CVSA balance_sheet (annual, 2023-06-30) — Common Stock: 822000.00
CVSA balance_sheet (annual, 2023-06-30) — Common Stock Equity: 1457336000.00
CVSA cash_flow (annual, 2023-06-30) — Common Stock Payments: -123133000.00
CVSA balance_sheet (annual, 2023-06-30) — Construction In Progress: 23390000.00
CVSA income_statement (annual, 2023-06-30) — Cost Of Revenue: 648486000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Accrued Expenses: 157847000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Assets: 480297000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 37673000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 37673000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Deferred Liabilities: 153871000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Deferred Revenue: 153871000.00
CVSA balance_sheet (annual, 2023-06-30) — Current Liabilities: 431203000.00
CVSA cash_flow (annual, 2023-06-30) — Deferred Income Tax: -5087000.00
CVSA cash_flow (annual, 2023-06-30) — Deferred Tax: -5087000.00
CVSA cash_flow (annual, 2023-06-30) — Depreciation: 89846000.00
CVSA cash_flow (annual, 2023-06-30) — Depreciation Amortization Depletion: 151085000.00
CVSA cash_flow (annual, 2023-06-30) — Depreciation And Amortization: 151085000.00
CVSA income_statement (annual, 2023-06-30) — Diluted Average Shares: 45600000.00
CVSA income_statement (annual, 2023-06-30) — Diluted EPS: 2.05
CVSA income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: 93358000.00
CVSA income_statement (annual, 2023-06-30) — EBIT: 170281000.00
CVSA income_statement (annual, 2023-06-30) — EBITDA: 321366000.00
CVSA cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 0.00
CVSA cash_flow (annual, 2023-06-30) — End Cash Position: 275075000.00
CVSA cash_flow (annual, 2023-06-30) — Financing Cash Flow: -288515000.00
CVSA cash_flow (annual, 2023-06-30) — Free Cash Flow: 165900000.00
CVSA cash_flow (annual, 2023-06-30) — Gain Loss On Investment Securities: 3689000.00
CVSA cash_flow (annual, 2023-06-30) — Gain Loss On Sale Of PPE: 3999000.00
CVSA income_statement (annual, 2023-06-30) — Gain On Sale Of Ppe: 13317000.00
CVSA income_statement (annual, 2023-06-30) — Gain On Sale Of Security: -3689000.00
CVSA balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (annual, 2023-06-30) — Goodwill: 961262000.00
CVSA balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 1773600000.00
CVSA balance_sheet (annual, 2023-06-30) — Gross Accounts Receivable: 134075000.00
CVSA balance_sheet (annual, 2023-06-30) — Gross PPE: 757955000.00
CVSA income_statement (annual, 2023-06-30) — Gross Profit: 802340000.00
CVSA cash_flow (annual, 2023-06-30) — Income Tax Paid Supplemental Data: 12312000.00
CVSA income_statement (annual, 2023-06-30) — Interest Expense: 58246000.00
CVSA income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 58246000.00
CVSA income_statement (annual, 2023-06-30) — Interest Income: 10654000.00
CVSA income_statement (annual, 2023-06-30) — Interest Income Non Operating: 10654000.00
CVSA cash_flow (annual, 2023-06-30) — Interest Paid Supplemental Data: 53126000.00
CVSA balance_sheet (annual, 2023-06-30) — Invested Capital: 2152413000.00
CVSA cash_flow (annual, 2023-06-30) — Investing Cash Flow: 23739000.00
CVSA cash_flow (annual, 2023-06-30) — Issuance Of Debt: 0.00
CVSA balance_sheet (annual, 2023-06-30) — Land And Improvements: 35956000.00
CVSA balance_sheet (annual, 2023-06-30) — Leases: 99777000.00
CVSA balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 163441000.00
CVSA balance_sheet (annual, 2023-06-30) — Long Term Debt: 695077000.00
CVSA balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 858518000.00
CVSA cash_flow (annual, 2023-06-30) — Long Term Debt Issuance: 0.00
CVSA cash_flow (annual, 2023-06-30) — Long Term Debt Payments: -150861000.00
CVSA balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 217806000.00
CVSA income_statement (annual, 2023-06-30) — Minority Interests: 0.00
CVSA cash_flow (annual, 2023-06-30) — Net Business Purchase And Sale: 0.00
CVSA cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: -123133000.00
CVSA balance_sheet (annual, 2023-06-30) — Net Debt: 422883000.00
CVSA income_statement (annual, 2023-06-30) — Net Income: 93358000.00
CVSA income_statement (annual, 2023-06-30) — Net Income Common Stockholders: 93358000.00
CVSA income_statement (annual, 2023-06-30) — Net Income Continuous Operations: 101752000.00
CVSA income_statement (annual, 2023-06-30) — Net Income Discontinuous Operations: -8394000.00
CVSA income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: 93358000.00
CVSA income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: 101752000.00
CVSA cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: 101752000.00
CVSA income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: 93358000.00
CVSA income_statement (annual, 2023-06-30) — Net Interest Income: -52502000.00
CVSA cash_flow (annual, 2023-06-30) — Net Investment Purchase And Sale: 6127000.00
CVSA cash_flow (annual, 2023-06-30) — Net Issuance Payments Of Debt: -150861000.00
CVSA cash_flow (annual, 2023-06-30) — Net Long Term Debt Issuance: -150861000.00
CVSA income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: -52502000.00
CVSA cash_flow (annual, 2023-06-30) — Net Other Financing Charges: -17754000.00
CVSA cash_flow (annual, 2023-06-30) — Net Other Investing Changes: 46800000.00
CVSA balance_sheet (annual, 2023-06-30) — Net PPE: 419326000.00
CVSA balance_sheet (annual, 2023-06-30) — Net Tangible Assets: -316264000.00
CVSA balance_sheet (annual, 2023-06-30) — Non Current Deferred Assets: 56694000.00
CVSA balance_sheet (annual, 2023-06-30) — Non Current Deferred Liabilities: 26068000.00
CVSA balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Assets: 56694000.00
CVSA balance_sheet (annual, 2023-06-30) — Non Current Deferred Taxes Liabilities: 26068000.00
CVSA income_statement (annual, 2023-06-30) — Normalized EBITDA: 373160000.00
CVSA income_statement (annual, 2023-06-30) — Normalized Income: 148792148.95
CVSA cash_flow (annual, 2023-06-30) — Operating Cash Flow: 191914000.00
CVSA cash_flow (annual, 2023-06-30) — Operating Gains Losses: -5700000.00
CVSA income_statement (annual, 2023-06-30) — Operating Income: 216331000.00
CVSA income_statement (annual, 2023-06-30) — Operating Revenue: 1439082000.00
CVSA balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 42310000.00
CVSA cash_flow (annual, 2023-06-30) — Other Cash Adjustment Outside Changein Cash: 0.00
CVSA balance_sheet (annual, 2023-06-30) — Other Current Assets: 102473000.00
CVSA balance_sheet (annual, 2023-06-30) — Other Equity Adjustments: -2227000.00
CVSA income_statement (annual, 2023-06-30) — Other Income Expense: -51794000.00
CVSA balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 812338000.00
CVSA cash_flow (annual, 2023-06-30) — Other Non Cash Items: 9129000.00
CVSA balance_sheet (annual, 2023-06-30) — Other Non Current Assets: 80624000.00
CVSA balance_sheet (annual, 2023-06-30) — Other Non Current Liabilities: 37416000.00
CVSA income_statement (annual, 2023-06-30) — Other Non Operating Income Expenses: 6965000.00
CVSA balance_sheet (annual, 2023-06-30) — Other Properties: 174677000.00
CVSA income_statement (annual, 2023-06-30) — Other Special Charges: -56000.00
CVSA balance_sheet (annual, 2023-06-30) — Payables: 81812000.00
CVSA balance_sheet (annual, 2023-06-30) — Payables And Accrued Expenses: 239659000.00
CVSA income_statement (annual, 2023-06-30) — Pretax Income: 112035000.00
CVSA cash_flow (annual, 2023-06-30) — Proceeds From Stock Option Exercised: 3233000.00
CVSA balance_sheet (annual, 2023-06-30) — Properties: 0.00
CVSA cash_flow (annual, 2023-06-30) — Provisionand Write Offof Assets: 32999000.00
CVSA cash_flow (annual, 2023-06-30) — Purchase Of Business: 0.00
CVSA cash_flow (annual, 2023-06-30) — Purchase Of Investment: -1508000.00
CVSA balance_sheet (annual, 2023-06-30) — Receivables: 102749000.00
CVSA income_statement (annual, 2023-06-30) — Reconciled Cost Of Revenue: 648486000.00
CVSA income_statement (annual, 2023-06-30) — Reconciled Depreciation: 151085000.00
CVSA cash_flow (annual, 2023-06-30) — Repayment Of Debt: -150861000.00
CVSA cash_flow (annual, 2023-06-30) — Repurchase Of Capital Stock: -123133000.00
CVSA balance_sheet (annual, 2023-06-30) — Restricted Cash: 2881000.00
CVSA income_statement (annual, 2023-06-30) — Restructuring And Mergern Acquisition: 61478000.00
CVSA balance_sheet (annual, 2023-06-30) — Retained Earnings: 2403750000.00
CVSA cash_flow (annual, 2023-06-30) — Sale Of Investment: 7635000.00
CVSA income_statement (annual, 2023-06-30) — Selling General And Administration: 586009000.00
CVSA balance_sheet (annual, 2023-06-30) — Share Issued: 82232000.00
CVSA income_statement (annual, 2023-06-30) — Special Income Charges: -48105000.00
CVSA cash_flow (annual, 2023-06-30) — Stock Based Compensation: 14299000.00
CVSA balance_sheet (annual, 2023-06-30) — Stockholders Equity: 1457336000.00
CVSA balance_sheet (annual, 2023-06-30) — Tangible Book Value: -316264000.00
CVSA income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: -4753851.05
CVSA income_statement (annual, 2023-06-30) — Tax Provision: 10283000.00
CVSA income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.09
CVSA balance_sheet (annual, 2023-06-30) — Total Assets: 2810541000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Capitalization: 2152413000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Debt: 896191000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 1457336000.00
CVSA income_statement (annual, 2023-06-30) — Total Expenses: 1234495000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 1353205000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 2330244000.00
CVSA balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 922002000.00
CVSA income_statement (annual, 2023-06-30) — Total Operating Income As Reported: 168170000.00
CVSA income_statement (annual, 2023-06-30) — Total Other Finance Cost: 4910000.00
CVSA income_statement (annual, 2023-06-30) — Total Unusual Items: -51794000.00
CVSA income_statement (annual, 2023-06-30) — Total Unusual Items Excluding Goodwill: -51794000.00
CVSA balance_sheet (annual, 2023-06-30) — Treasury Shares Number: 39922000.00
CVSA balance_sheet (annual, 2023-06-30) — Treasury Stock: 1513770000.00
CVSA balance_sheet (annual, 2023-06-30) — Working Capital: 49094000.00
CVSA income_statement (annual, 2024-06-30) — +Operating Expense: 632965000.00
CVSA income_statement (annual, 2024-06-30) — +Total Revenue: 1584652000.00
CVSA balance_sheet (annual, 2024-06-30) — Accounts Payable: 102626000.00
CVSA balance_sheet (annual, 2024-06-30) — Accounts Receivable: 126833000.00
CVSA balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: -326279000.00
CVSA balance_sheet (annual, 2024-06-30) — Additional Paid In Capital: 611949000.00
CVSA balance_sheet (annual, 2024-06-30) — Allowance For Doubtful Accounts Receivable: -37812000.00
CVSA cash_flow (annual, 2024-06-30) — Amortization Cash Flow: 35644000.00
CVSA cash_flow (annual, 2024-06-30) — Amortization Of Intangibles: 35644000.00
CVSA income_statement (annual, 2024-06-30) — Basic Average Shares: 39413000.00
CVSA income_statement (annual, 2024-06-30) — Basic EPS: 3.47
CVSA cash_flow (annual, 2024-06-30) — Beginning Cash Position: 275075000.00
CVSA balance_sheet (annual, 2024-06-30) — Buildings And Improvements: 200274000.00
CVSA cash_flow (annual, 2024-06-30) — Capital Expenditure: -48893000.00
CVSA cash_flow (annual, 2024-06-30) — Capital Expenditure Reported: -48893000.00
CVSA balance_sheet (annual, 2024-06-30) — Capital Lease Obligations: 199141000.00
CVSA balance_sheet (annual, 2024-06-30) — Capital Stock: 832000.00
CVSA balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 219306000.00
CVSA balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 219306000.00
CVSA cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Financing Activities: -301798000.00
CVSA cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Investing Activities: -47850000.00
CVSA cash_flow (annual, 2024-06-30) — Cash Flow From Continuing Operating Activities: 288367000.00
CVSA cash_flow (annual, 2024-06-30) — Cash From Discontinued Investing Activities: 0.00
CVSA cash_flow (annual, 2024-06-30) — Cash From Discontinued Operating Activities: 7408000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Account Payable: 18330000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Accrued Expense: 46844000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Other Current Assets: -27154000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Other Current Liabilities: -36692000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Other Working Capital: 30895000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Payable: 18330000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Payables And Accrued Expense: 65174000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Prepaid Assets: -8781000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Receivables: -76355000.00
CVSA cash_flow (annual, 2024-06-30) — Change In Working Capital: -52913000.00
CVSA cash_flow (annual, 2024-06-30) — Changes In Account Receivables: -76355000.00
CVSA cash_flow (annual, 2024-06-30) — Changes In Cash: -53873000.00
CVSA balance_sheet (annual, 2024-06-30) — Common Stock: 832000.00
CVSA balance_sheet (annual, 2024-06-30) — Common Stock Equity: 1369135000.00
CVSA cash_flow (annual, 2024-06-30) — Common Stock Payments: -261966000.00
CVSA balance_sheet (annual, 2024-06-30) — Construction In Progress: 11554000.00
CVSA income_statement (annual, 2024-06-30) — Cost Of Revenue: 698548000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Accrued Expenses: 168330000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Assets: 418085000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Capital Lease Obligation: 31429000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Debt And Capital Lease Obligation: 31429000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Deferred Liabilities: 185272000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Deferred Revenue: 185272000.00
CVSA balance_sheet (annual, 2024-06-30) — Current Liabilities: 487657000.00
CVSA cash_flow (annual, 2024-06-30) — Deferred Income Tax: 11073000.00
CVSA cash_flow (annual, 2024-06-30) — Deferred Tax: 11073000.00
CVSA cash_flow (annual, 2024-06-30) — Depreciation: 72317000.00
CVSA cash_flow (annual, 2024-06-30) — Depreciation Amortization Depletion: 107961000.00
CVSA cash_flow (annual, 2024-06-30) — Depreciation And Amortization: 107961000.00
CVSA income_statement (annual, 2024-06-30) — Diluted Average Shares: 40307000.00
CVSA income_statement (annual, 2024-06-30) — Diluted EPS: 3.39
CVSA income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: 136777000.00
CVSA income_statement (annual, 2024-06-30) — EBIT: 218196000.00
CVSA income_statement (annual, 2024-06-30) — EBITDA: 326157000.00
CVSA cash_flow (annual, 2024-06-30) — End Cash Position: 221202000.00
CVSA cash_flow (annual, 2024-06-30) — Financing Cash Flow: -301798000.00
CVSA cash_flow (annual, 2024-06-30) — Free Cash Flow: 246882000.00
CVSA cash_flow (annual, 2024-06-30) — Gain Loss On Investment Securities: -1365000.00
CVSA cash_flow (annual, 2024-06-30) — Gain Loss On Sale Of PPE: 466000.00
CVSA income_statement (annual, 2024-06-30) — Gain On Sale Of Ppe: 0.00
CVSA income_statement (annual, 2024-06-30) — Gain On Sale Of Security: 1365000.00
CVSA balance_sheet (annual, 2024-06-30) — Gains Losses Not Affecting Retained Earnings: -2227000.00
CVSA balance_sheet (annual, 2024-06-30) — Goodwill: 961262000.00
CVSA balance_sheet (annual, 2024-06-30) — Goodwill And Other Intangible Assets: 1737956000.00
CVSA balance_sheet (annual, 2024-06-30) — Gross Accounts Receivable: 164645000.00
CVSA balance_sheet (annual, 2024-06-30) — Gross PPE: 751558000.00
CVSA income_statement (annual, 2024-06-30) — Gross Profit: 886104000.00
CVSA cash_flow (annual, 2024-06-30) — Income Tax Paid Supplemental Data: 31475000.00
CVSA income_statement (annual, 2024-06-30) — Interest Expense: 54259000.00
CVSA income_statement (annual, 2024-06-30) — Interest Expense Non Operating: 54259000.00
CVSA income_statement (annual, 2024-06-30) — Interest Income: 9177000.00
CVSA income_statement (annual, 2024-06-30) — Interest Income Non Operating: 9177000.00
CVSA cash_flow (annual, 2024-06-30) — Interest Paid Supplemental Data: 57842000.00
CVSA balance_sheet (annual, 2024-06-30) — Invested Capital: 2017847000.00
CVSA cash_flow (annual, 2024-06-30) — Investing Cash Flow: -47850000.00
CVSA cash_flow (annual, 2024-06-30) — Issuance Of Debt: 1896000.00
CVSA balance_sheet (annual, 2024-06-30) — Land And Improvements: 31776000.00
CVSA balance_sheet (annual, 2024-06-30) — Leases: 114019000.00
CVSA balance_sheet (annual, 2024-06-30) — Long Term Capital Lease Obligation: 167712000.00
CVSA balance_sheet (annual, 2024-06-30) — Long Term Debt: 648712000.00
CVSA balance_sheet (annual, 2024-06-30) — Long Term Debt And Capital Lease Obligation: 816424000.00
CVSA cash_flow (annual, 2024-06-30) — Long Term Debt Issuance: 1896000.00
CVSA cash_flow (annual, 2024-06-30) — Long Term Debt Payments: -51896000.00
CVSA balance_sheet (annual, 2024-06-30) — Machinery Furniture Equipment: 217180000.00
CVSA cash_flow (annual, 2024-06-30) — Net Business Purchase And Sale: 0.00
CVSA cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: -261966000.00
CVSA balance_sheet (annual, 2024-06-30) — Net Debt: 429406000.00
CVSA income_statement (annual, 2024-06-30) — Net Income: 136777000.00
CVSA income_statement (annual, 2024-06-30) — Net Income Common Stockholders: 136777000.00
CVSA income_statement (annual, 2024-06-30) — Net Income Continuous Operations: 137713000.00
CVSA income_statement (annual, 2024-06-30) — Net Income Discontinuous Operations: -936000.00
CVSA income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: 136777000.00
CVSA income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: 137713000.00
CVSA cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: 137713000.00
CVSA income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: 136777000.00
CVSA income_statement (annual, 2024-06-30) — Net Interest Income: -54482000.00
CVSA cash_flow (annual, 2024-06-30) — Net Investment Purchase And Sale: 1043000.00
CVSA cash_flow (annual, 2024-06-30) — Net Issuance Payments Of Debt: -50000000.00
CVSA cash_flow (annual, 2024-06-30) — Net Long Term Debt Issuance: -50000000.00
CVSA income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: -54482000.00
CVSA cash_flow (annual, 2024-06-30) — Net Other Financing Charges: -7731000.00
CVSA balance_sheet (annual, 2024-06-30) — Net PPE: 425279000.00
CVSA balance_sheet (annual, 2024-06-30) — Net Tangible Assets: -368821000.00
CVSA balance_sheet (annual, 2024-06-30) — Non Current Deferred Assets: 49088000.00
CVSA balance_sheet (annual, 2024-06-30) — Non Current Deferred Liabilities: 29526000.00
CVSA balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Assets: 49088000.00
CVSA balance_sheet (annual, 2024-06-30) — Non Current Deferred Taxes Liabilities: 29526000.00
CVSA income_statement (annual, 2024-06-30) — Normalized EBITDA: 360877000.00
CVSA income_statement (annual, 2024-06-30) — Normalized Income: 166877800.00
CVSA cash_flow (annual, 2024-06-30) — Operating Cash Flow: 295775000.00